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Abstract—The measurement of the biological tissue’s electrical
impedance is an active research field that has attracted a lot
of attention during the last decades. Bio-impedances are closely
related to a large variety of physiological conditions; therefore,
they are useful for diagnosis and monitoring in many medical
applications. Measuring living tissues, however, is a challenging
task that poses countless technical and practical problems, in
particular if the tissues need to be measured under the skin.
This paper presents a bio-impedance sensor ASIC targeting a
battery-free, miniature size, implantable device, which performs
accurate 4-point complex impedance extraction in the frequency
range from 2 kHz to 2 MHz. The ASIC is fabricated in 150 nm
CMOS, has a size of 1.22 mm × 1.22 mm and consumes 165 µA
from a 1.8 V power supply. The ASIC is embedded in a prototype
which communicates with, and is powered by an external reader
device through inductive coupling. The prototype is validated
by measuring the impedances of different combinations of dis-
crete components, measuring the electrochemical impedance of
physiological solution, and performing ex vivo measurements on
animal organs. The proposed ASIC is able to extract complex
impedances with around 1 Ω resolution; therefore enabling
accurate wireless tissue measurements.
Index Terms—Bio-Impedance, Implantable device, Battery-
less, System-on-Chip (ASIC), Impedance Spectroscopy.
I. INTRODUCTION
THE electrical impedance of the biological tissue, com-monly referred as bio-impedance, is a function of physio-
logical processes and therefore offers interesting opportunities
for monitoring a variety of bio-markers. Its potential use
in medical applications was already identified more than a
century ago [1]. Currently, bio-impedance research is still
a growing field of study and its advances find spread use
in many medical applications. Among others, bio-impedance
characterization is the principle behind Electrical Impedance
Tomography (EIT) [2], which has wide use in applications
such as lung function monitoring, breast cancer detection,
cervical intraepithelial neoplasia prediction, brain imaging,
etc. Bio-impedance is also being successfully used to detect
different types of skin cancer [3]. In addition, bio-impedance
measurements are being used as part of complementary tools
to remove artifacts in other kind of measurements such as in
ECG [4],[5],[6],[7]. Typically, bio-impedance is extracted at a
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Fig. 1. Bio-impedance measuring system concept
single frequency in these applications. Furthermore, surgical
instrumentation controlled by bio-impedance measurements
has been recently proposed [8]. Other applications include
body fluid analysis and cell characterization for wearable
and implantable health care applications [9],[10], [11], Kelvin
impedance sensing to detect biomolecular interactions [12],
and myocardial ischemia detection [13].
The measurement of bio-impedance using non-invasive
methods, such as measurements on the skin, are plagued
with artifacts [14] that make enormously difficult to cor-
rectly characterize the tissue under test. Furthermore, a
rigorous electrical characterization of internal organs’ tissues
under different physiological conditions needs the analysis of
complex impedances at many frequency points over several
decades (impedance spectroscopy). Accordingly, implantable
devices for measuring bio-impedance of tissues under the skin
(i.e. muscle, bone, blood, etc.) which are able to perform
impedance spectroscopy are necessary. Implantable sensors,
however, have stringent limitations [15] in size, power, and
communication means which define to a great extent the way
in which the bio-impedance sensor is built.
For practical and medical reasons, the size of an implantable
device should be as small as possible, so miniaturization of
the system becomes a consideration of paramount importance.
In addition, it should not have wires to the external world;
therefore, it requires some means of wireless communication
[16]. Likewise, providing electrical power to the implantable
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TABLE I
DESIGN SPECIFICATIONS FOR THE IMPLANTABLE SENSOR
Name Specification
Power source Inductive coupling
Wireless Comm. ASK over inductive coupling
Powering Distance > 4 cm
Dimensions Approx. 13 mm × 3 mm
Measured Quantity Complex Impedance
Meas. Technique 4-terminal
Resolution Approx. 1 Ω
Freq. Range 2 kHz - 2 MHz
device is a major challenge. The use of batteries is strongly
discouraged since they have a limited lifespan and also have a
strong impact on the form factor. Energy harvesting techniques
such as inductive coupling are preferred since power transfer
and wireless communication can be achieved at the same
time [17],[18],[19]. The inductive harvesters, however, are able
to extract only limited amounts of power at large distances
(low efficiencies); therefore, ultra-low power design techniques
must be employed to build the implantable electronic circuits.
This paper presents a low power bio-impedance sensor
ASIC that targets a miniature-size, battery-free implantable
device. The ASIC is used in the bio-impedance sensing system
presented in Fig. 1. The objective of this system is to perform
impedance spectroscopy of animal and human living tissues
from 2 kHz to 2 MHz (11 points logarithmically spaced). The
implantable device is externally powered by a reader device
using inductive coupling. In addition, inductive coupling is
used to establish two-way half-duplex communication between
the reader and the implantable device. The reader device is
connected to an Android mobile phone by using Bluetooth. A
software application including a graphic user interface (GUI)
is used to send control orders to the implantable device,
perform digital signal processing (post processing/calibration),
and present measurement results. The sensor ASIC is able
to extract complex impedances from 2 kHz to 2 MHz with
around 1 Ω resolution after calibration. Table I shows a
summary of the implantable device specifications. The paper
is organized as follows. The complete bio-impedance sensing
system architecture is described in Section II. The details
of the different building blocks in the ASIC are shown in
Section III. System integration and validation of the proposed
bio-impedance sensor are presented in Section IV. Finally,
conclusions are drawn in Section V.
II. IMPLANTABLE SENSOR ARCHITECTURE
The bio-impedance sensor architecture depends completely
on the impedance measurement technique that is used. Two-
terminal auto-balance bridge with digital calibration [20] is
an amenable technique for integration in implantable devices
since it requires only two electrodes. However, this technique
has the drawback that it also measures the interface elec-
trode impedances which can be much larger than the tissue’s
impedance. Removal of the electrode interface impedances is
aggravated by mismatches which are difficult to estimate and
therefore difficult to subtract. On the other hand, 4-terminal
measurements alleviate the issue of the electrode interface
impedance at the price of an extra pair of electrodes [21]. In
this work, a 4-terminal impedance sensing method has been
used to measure the tissue impedances.
Fig. 2 shows all the components of the bio-impedance sens-
ing system: Android phone, external reader, and implantable
device. As can be seen in Fig. 2, the selected architecture
is based on sinusoidal current injection, voltage sensing, and
in-phase (I) and quadrature (Q) separation. The principle of
operation is as follows.
A sinusoidal differential current I with known amplitude,
frequency, and phase is injected on the two external electrodes,
and the differential voltage drop V is sensed on the other two
internal electrodes. A complex impedance Z = |Z|ejθ in the
path of I results in V being proportional to I and “modulated”
both in amplitude and phase. Using phasor representation, V
can be expressed as:
V = |I|ejωt × Z = |I||Z|ejωtejθ = |I||Z|ej(ωt+θ) (1)
Extraction of the real and imaginary parts of the complex
impedance is done by using in-phase (I) and quadrature (Q)
demodulation, respectively. For the in-phase component, the
sensed voltage is multiplied by cos(ωt) so that:
VI = |I||Z|ej(ωt+θ)cos(ωt)
= |I||Z|(cos(ωt+ θ) + jsin(ωt+ θ))cos(ωt)
= |I||Z|
(cos(θ)
2
+
cos(2ωt+ θ)
2
+
jsin(ωt+ θ))cos(ωt)
) (2)
which after low-pass filtering becomes:
VI,DC = |I||Z|cos(θ)
2
(3)
Then, the real part can be recovered as:
Re{Z} = |Z|cos(θ) = 2VI,DC|I| (4)
For the quadrature component, the sensed voltage is multiplied
by sin(ωt) instead, and after similar treatment, the imaginary
part of Z is:
Im{Z} = |Z|sin(θ) = 2VQ,DC|I| (5)
The I/Q demodulation requires the design of a very linear
analog multiplier and generation of very clean I/Q sinusoidal
signals. An alternative is the use of a current commutating
passive mixer that is controlled by I/Q digital clock signals.
The main advantages of this approach is that the passive mixer
is inherently highly-linear, and does not consume any power.
In addition, the generation of I/Q clocks are purely digital,
and therefore easy to implement.
The mixing process entails time-domain multiplication of
V by a square wave instead of a pure sinusoidal wave. In
particular, the result of interest is the multiplication of V
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Fig. 2. Proposed bio-impedance sensing system
by the fundamental harmonic (4/pi)cos(ωt) for the in-phase
component, or by (4/pi)sin(ωt) for the Q component. In
addition, the demodulator chain amplifies the signal by a factor
G so that the quantization at the analog-to-digital converter
(ADC) does not degrade the signal-to-noise ratio (SNR). When
these details are taken in consideration, the expressions for
Re{Z} and Im{Z} become:
Re{Z} = |Z|cos(θ) = pi
2
VI,DC
|I|G (6)
Im{Z} = |Z|sin(θ) = pi
2
VQ,DC
|I|G (7)
Since the outputs of the I/Q demodulation are DC signals, it
is unnecessary to demodulate the I/Q paths simultaneously by
using two demodulator chains. Instead, it is possible to save
area and power by using a single demodulator chain which is
multiplexed in time. As shown in the block diagram of Fig. 2,
this is easily implemented by using a digital configuration line
which selects the I or Q clock that is used by the demodulator.
The sinusoidal current source generation, frequency synthe-
sis, and I/Q demodulation blocks are also integrated in the bio-
impedance ASIC, as it can be seen in Fig. 2, and their design
is described in detail in Section III. The following subsections
provide brief descriptions of the external blocks of the sys-
tem: electrodes, circular coil, low power microcontroller, and
external reader.
A. Electrodes
The geometry of the sensing electrodes is of paramount
importance in impedance sensing. The limited dimensions of
Fig. 3. EM simulation of the electrodes and tissue
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+
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Fig. 4. Electrodes and tissue model as a 2-port network
the implantable device demand the use of small geometries
in which current injecting electrodes are close to the voltage
sensing electrodes. Relatively small dimensions are advanta-
geous in this application because electromagnetic fields are
contained in a small space, and therefore, they allow only
impedance extraction of the tissue of interest in the vicinity of
the device. The geometry of the electrodes is also important
because it defines the magnitude of the sensed impedance;
hence, it sets specifications for the impedance range that the
analog front-end circuits must be able to handle.
In this work, the electrode configuration shown in Fig. 3 is
used. The electrodes are made of gold (ENIG Ni/Au process)
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on a 0.75 mm hydrocarbon ceramic substrate Rogers 4000.
An estimation of the tissue’s impedance magnitude that can
be detected by these electrodes is obtained by performing
Electromagnetic (EM) momentum simulation using Agilent
ADS in which the tissue is modeled as a 3 cm semi-
conductor layer stacked on the top of the electrodes. Values
of permittivity (εr) and conductivity (σ) are extracted from
[22] and [23] for different types of tissues. The electrodes
are treated as a 2-port network in which the injecting current
electrodes (rectangle shapes) are defined as differential port1,
and the voltage sensing electrodes (circle shapes) are defined
as differential port2 (Fig. 4). S-parameters are extracted and
converted to Z-parameters. The parameter Z21 = V2/I1 which
is calculated for I2 = 0 corresponds to the sensed impedance.
This simulation disregards the interface resistances Rint be-
tween the electrodes and tissue which depends on many
factors. However, the results are valid since for these small
geometries, the interface resistances only add in series to the
total impedance seen from the injecting and sensing electrodes.
More important, these resistances can be disregarded at the
voltage sensing electrodes provided that the input amplifier
presents very high impedance (there are no voltage drops on
the interface resistances since I2 ≈ 0). The lowest impedance
Z21, which takes a value of approximately 107 Ω at low
frequencies, is obtained in the case of blood (σ ≈ 0.7 S/m).
Likewise, the largest impedance, which takes a simulated value
of approximately 2491 Ω at low frequencies, is for the case
of skeletal transversal muscle tissue (σ ≈ 0.03 S/m).
B. Circular coil
Remote powering and communication of implantable de-
vices by using inductive coupling has been successfully shown
at distances from a few millimeters to several centimeters
[24], [25]. Power levels in the order of several mW have
been harvested with relatively good transfer efficiencies up to
around 40%. By using rotating magnets and low frequencies
close to hundreds of Hz, power quantities of several Watts
can be harvested with transfer efficiencies as high as 50% [26].
Nevertheless, so low frequencies demand large inductance val-
ues which occupy large sizes and therefore are not amenable
for integration in miniature implantable devices. In addition,
they make difficult the use of the inductive coupling for
communication purposes since the communication bandwidth
is commonly only a fraction of the operating frequency. In this
work, inductive coupling is implemented by using standard
circular coils and an operating frequency of 13.56 MHz (ISM
band). The secondary coil in the implantable device is made
of 0.25 mm diameter, enamelled copper wire. The circular
coil has 7 turns, and 12 mm diameter which results in an
inductance of 1.3 µH.
C. Low-power microcontroller
A low-power microcontroller PIC16LF1823 from Mi-
crochip was selected for this work since it provides a robust
and flexible digital solution in a small footprint. The microcon-
troller is housed in a QFN-32 package (4 mm × 4 mm), and
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Fig. 5. Communications and power management block diagram
it is used to control the bio-impedance sensor ASIC through a
Serial Periphelal Interface (SPI) bus, to handle asynchronous
serial communications with the reader, to provide a calibrated
500 kHz clock reference and 10-bit analog-to-digital conver-
sion. The micro-controller consumes close to 2 µA when the
firmware is running a waiting loop at 32-kHz, and around
100 µA when executing code at 500 kHz.
D. External Reader
The external reader is a battery powered device that contains
an RN42 Bluetooth transceiver module, a 13.56 MHz crystal
oscillator, a Class-E power amplifier, the primary inductor
composed of a 1.8 µH circular coil (4 cm diameter), and
an Amplitude Shift Keying (ASK) modulator/demodulator.
The tasks of the reader are to provide wireless power to the
implantable device through inductive coupling, and to relay
data from/to the Android phone and the implantable device.
III. BIO-IMPEDANCE ASIC DESIGN
The Bio-impedance ASIC was designed using a 150 nm
1.8 V CMOS process, and integrates the following blocks:
SPI configuration, power management and communications,
frequency synthesis, current signal generator, voltage sensing
and I/Q demodulation, and low pass filter. The following
subsections describe these building blocks.
A. SPI Configuration
The ASIC is configured through a SPI digital interface
which is built by using a chain of registers. The inputs for
this stage are a clear (reset) signal, serial data, clock data,
and strobe. These configuration signals are provided by the
microcontroller. A configuration word includes 2 calibration
bits for the frequency synthesis block, 4 bits for frequency
selection, 1 bit for enabling/disabling the signal source, 1 bit
for selection of I/Q clock, and 3 bits that control the variable
gain amplification.
B. Power Management and Serial Data Transmission
Fig. 5 shows the power management and communication
block diagram. The secondary circular coil and a parallel
capacitor are tuned at the operating frequency 13.56 MHz.
When the external reader is in the vicinity of the implantable
device, AC voltage is induced in this LC tank circuit. A full-
wave rectifier based on [27] and shown in Fig. 6 is used to
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Fig. 6. Rectifier circuit
convert the AC voltage in an unregulated DC voltage source.
The MOS devices in the rectifier are directly exposed to
large voltage variations which depend on the proximity of the
external reader. Two design considerations have been applied
in order to protect these devices. First, 3.3 V transistors,
which have a thicker oxide and higher breakdown voltage than
their 1.8 V counterparts, have been used. Next, the PMOS
diode chain composed of M5, M6, and M7 is used in a
similar way to a Zener diode. The chain starts conducting at
around 2 V and maintains the maximum unregulated voltage
at around 3 V, while dissipating the excess of induced power.
An additional consideration is that the pads connected to
the coil terminals are by necessity disconnected from the
ESD protection circuits. In this case, the PMOS diode chain
provides an ESD protection mechanism to the devices in the
rectifier since it also sinks currents produced during ESD
events. Finally, the switch M8 is used to transmit data to the
reader by performing load modulation on the LC tank.
The unregulated voltage is stored on a 20 µF SM0603
external capacitor. This capacitor acts as an energy reservoir
and it is necessary since during some instants of the serial
data transmission, the LC tank is short-circuited when M8 is
activated. During these short intervals, this capacitor slowly
discharges while sourcing the necessary power to the circuits.
When M8 is deactivated, the rectifier charges again the capac-
itor.
A low drop-out regulator (LDO) and a 1.22 V bandgap
reference generate a 1.8 V power supply for the entire chip.
A constant GM stage powered from the unregulated voltage
line is used to provide biasing currents to both the LDO and
the bandgap reference circuit. These currents have rather large
variations, so they are only used in these two circuits. The
biasing currents for the different blocks in the chip are instead
derived from a current reference generated directly from the
bandgap stage.
C. Serial Data Reception
Fig. 7 shows the ASK demodulation circuits which is
composed of a diode-based AM demodulator that is connected
to one terminal of the secondary coil. The output of the
demodulator is followed by a buffer (A1). The DC signal at
the output of the demodulator depends on the proximity to the
A1 A2
A3Vcc
2
Vcc
2
Vc
RxData
R1 R1 2R1
R2 R2
R2
Secondary
coil
Fig. 7. ASK demodulator
reader and could be in some cases as high as several volts.
Accordingly, the input of the buffer is taken from a voltage
divider so that the DC input level is within the 1.8 V range.
The circuit configuration around A2 extracts the DC level of
the demodulated signal and inverts its sign. Then, the voltage
adder formed by A3 subtracts the buffered signal from its DC
level, amplifies it, and centers the DC level at 0.9 V. Finally,
a comparator extracts the received data. The sensitivity of the
demodulator is controlled by the comparison voltage VC .
D. Frequency Synthesis
The frequencies needed by bio-impedance ASIC are gen-
erated by using the fully integrated 32X PLL frequency
multiplier shown in Fig. 8. A 500 kHz reference clock coming
from the microcontroller produces a 16 MHz clock at the
output of the PLL. The frequency divider is implemented by
cascading 10 divide-by-two circuits made of D-type flip-flops.
The buffered output of the VCO and the outputs of the dividers
provide frequencies from 16 MHz down to 15.625 kHz. The
SPI digital configuration block selects one of these frequencies
by using a 16:1 multiplexer, as shown in Fig. 2.
The charge pump circuit is shown in Fig. 9 and includes
two calibration structures that allow to increase/decrease the
charge pump’s gain and therefore introduce a mechanism to
control the loop dynamics of the PLL (lock speed, ringing,
etc.). These calibration structures are directly controlled from
the SPI digital configuration block.
As it is shown in Fig. 10, the VCO consists of a 3-stage
ring-oscillator in which the oscillation frequency is controlled
by a transconductor stage formed by M1 and R1. A comparator
takes the VCO signal and outputs a rail-to-rail square wave.
The VCO’s gain is around 22 MHz/V.
E. Sinusoidal Signal and I/Q Generator
Fig. 11 shows the sinusoidal signal source and I/Q clock
generators. The output of the 16:1 multiplexer, which consists
of the selected frequency clock, is connected to the clk input of
a finite state machine (FSM). This FSM outputs five control
signals that are used to connect the output ports Vout+ and
Vout− to different nodes in a resistive voltage divider. The
resistors are sized and matched so that an 8-step sinusoidal
wave with an amplitude of 100 mV is available at the
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differential output Vout. The voltage divider is biased by 2 µA.
Two NMOS diodes are used to set the common-mode voltage
to a value close to 0.9 V. In addition, the FSM outputs in-phase
and quadrature square waves. Due to the way in which all these
signals are generated, the sinusoidal wave is always delayed
pi/8 rads (22.5◦) with respect to the I/Q signals. Hence, the
measured impedance after I/Q demodulation is rotated 22.5◦
in the complex plane. This is easily corrected later in software
(either in the microcontroller or Android phone) by rotating
the constellation with the same amount but in the opposite
direction .
The Enable input of the FSM is used to activate/deactivate
the sinusoidal signal generator. When it is deactivated, only the
control signal P1 is set, which produces a differential Vout = 0.
The sinusoidal voltage is converted into current by using
the variable transconductance circuit shown in Fig. 12. The
G0 and G1 configuration bits allow the selection of three
output current amplitude levels: 1.11 µA, 3.33 µA, and
10 µA. These differential currents are connected directly to
the current injection electrodes. Both the voltage divider and
P1
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P4
P5
Vout+Vout-
FI
N
IT
E
 S
T
A
T
E
 M
A
C
H
IN
E
clk Enable
Vout+
time
2uA
Q
I
I
time
Q
time
Vout-
Fig. 11. Sinusoidal source, I/Q generation, and time diagrams
G0 G1
G0,G1
Out+ Out-Vin+ Vin-
Vb
R1
CMFB 8uA 8uA
2uA 2uA6uA
2uA 4uA 12uA
Fig. 12. Current signal generator
the transconductance use the same type of poly resistor. Since
the output current is proportional to the ratio of the resistances,
process drifts in the same direction are canceled.
F. Voltage Amplification and I/Q Demodulation
Fig. 13 shows the voltage amplification and I/Q demod-
ulation chain. The voltage at the sensing electrodes is con-
verted into a differential current by using a low-noise variable
transconductance amplifier. The configuration bit G2 controls
the gain of the amplifier: when G2 is 1, GM = 20 µS,
where when it is 0, GM = 6.67 µS. The LNA’s output
current is multiplied by the I or Q square wave by using a
current commutating passive mixer. The output of the mixer
is connected to a transimpedance amplifier (TIA) that both
amplifies and partially removes high frequency components
by performing first order low-pass filtering.
Since the multiplication is done by using square wave
mixing, a careful frequency planning is needed in order to
avoid that the harmonics of the square wave and the harmonics
of the sinusoidal signal affect the final results. In this work, the
8-step sinusoidal signal presents harmonics centered around
frequencies which are multiples of 8 times the fundamental
frequency (8X, 16X, 24X, etc). The main concern is the
effect of the first harmonics which appear around 8 times the
fundamental frequency since their level is only approximately
20 dB below the fundamental component. These harmonics
are multiplied by the 7th and 9th harmonic of the square wave
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Fig. 13. Voltage amplification and I/Q demodulation
and their results appear superimposed on the desired result at
DC with around 40 dB attenuation. Accordingly, they would
introduce an error of approximately 1% in the measurement.
Nevertheless, most of the tissues behave as a low-pass filter in
the β region (10 kHz - 1 MHz), and therefore help to attenuate
the high frequency harmonics of the injected signal before the
mixing process takes place. As a result, the errors introduced
due to mixing the 8-step sinusoidal signal and the I/Q clocks
are below 1%.
G. Low-pass Filter and Buffer
The results of the I/Q demodulation are purely DC signals
and therefore high-frequency components coming from the
mixing process need to be completely suppressed. A first
order filtering is already provided by the TIA. The rest of
the filtering is performed in the GM-C low-pass filter shown
in Fig. 14. The filter consists of a second-order Chebyshev
filter with a cut-off frequency of 50 Hz. Such low frequencies
require external capacitors and extremely low GM values of
around 0.1 µS. These transconductances are achieved by using
the ratio of the output current mirrors as an attenuator factor
so that GM = N/(MR1), N < M .
The filtered signal is connected to the output buffers which
are designed to drive the output pads, PCB traces, and the
sample-and-hold circuit of the ADC.
One serious concern in this kind of continuous-time imple-
mentation is the effect of 1/f noise on the final DC mea-
surements. The following design considerations were applied
here. First, the demodulated signal at the input of the filter is
already amplified to at least a few hundred mV. This means
that the input-referred integrated noise that can be tolerated
to maintain the error level below 1% is in the order of a
couple of mVrms. Likewise, the quantization step of the 10-
bit ADC in the microcontroller is 1.75 mV. Therefore, noise
levels below this value are inoffensive, and design efforts to
reduce 1/f noise below this value will only result in increased
power consumption without any performance improvement.
In this work, the filter and buffer were designed so that a
simulated total output noise of around 1.3 mVrms is obtained
after integrating the noise in the relevant bandwidth (1 Hz -
100 Hz). Another important observation is that the output of
the I/Q demodulator is a DC signal whereas the 1/f noise
R1Vin+ Vin- Out-Out+
MN
Vb
CMFB CMFB
Vin
Out+
Out-
5uA 5uA
2uA 2uA3uA
CcRc Out
Vin
2uA
1uA
4uA
Fig. 14. Low-pass filter and buffer
is a random process with zero mean (no DC component).
This gives the opportunity to mitigate the 1/f noise by just
oversampling the output and applying averaging.
H. Functional Timing Diagram
Fig. 15 shows the functional timing diagram of the im-
plantable device including key waveforms from the ASIC.
Once a serial command is received (RX ), the current signal
generator and the I reference are activated. A differential
voltage drop on the tissue is sensed (Vin), amplified, and
demodulated. The transient of the demodulated signal (Vout)
settles in approximately 25 ms. The DC signal corresponding
to I is sampled by the ADC several times, and averaged.
Thereafter, the reference is switched to Q and after the
transient settles, the DC signal corresponding to Q is sampled
by the ADC several times, and averaged. Finally, the current
signal generator and the I/Q reference are disabled, and the
information transmitted to the reader (TX ).
Table II shows a performance summary of the ASIC includ-
ing the individual current consumption of each block.
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Fig. 15. Timing diagram
TABLE II
ASIC PERFORMANCE SUMMARY
Technology 150 nm CMOS
Size 1.22 mm × 1.22 mm
Power Supply 1.8 V
Total Current 165.5 µA
Current Consumption Distribution
Power Management + Comm. 16.5 µA
PLL 22.9 µA
Signal Generator 29.0 µA
LNA + Mixer 17.4 µA
TIA 9.2 µA
LPF 58.5 µA
Buffers 12.0 µA
IV. SYSTEM INTEGRATION AND MEASUREMENTS
The bio-impedance ASIC was fabricated in a 150 nm 1.8 V
CMOS process and bond-wired in a PLCC44 package for
testing purposes. The circuit blocks occupy an active area of
approximately 1.22 mm × 1.22 mm and consumes 165 µA.
The PCB prototype for the implantable device including a
micro-photograph of the ASIC is shown in Fig. 16. This PCB
prototype is only used for testing and validation purposes, and
includes testing points as well as programming circuitry for the
microcontroller. A version ready for in vivo testing contains
all the SMD components including the ASIC mounted at the
reverse of the electrodes. An inset of this version has been
added at the bottom-right corner of Fig. 16 for comparison
purposes.
A. Electrical Tests
Tests on powering and communication circuits show that the
inductive coupling is able to power correctly the implantable
device at distances up to 5 cm. The power efficiency at this
distance is around 0.3%, which is enough to provide the
minimum required power and communications to the device.
At shorter distances, much higher efficiencies are achieved
I/Q 
Demodulator
PLL
Signal 
Generator
SPI
Power 
Management
13
 m
m
Fig. 16. Bio-impedance ASIC chip photo and test prototype
Fig. 17. Serial communication demodulated waveforms
since the coupling coefficient increases. However, they are not
relevant as the main objective of this system is to measure
the bio-impedance of organs which can be located several cm
under the skin. These tests have been performed while sending
orders and receiving measurement data. This is important be-
cause power transfer is practically rendered ineffective during
some instants of the communication. Fig. 17 shows measured
waveforms of the half-duplex communication at the reader
when receiving data from the implantable prototype. The blue
waveform is measured at the output of the envelope detector,
whereas the red waveform is the 9.6 kbps serial data at the
input of the USART of the Bluetooth module.
Tests for validating the functionality of the signal generator
are shown in Fig. 18. The measured waveform of the 8-step
sinusoidal signal is taken at one of the voltage sensing inputs.
The measured spectrum of the waveform shows that the 7th
and 9th harmonics are the strongest ones and are located
around 20 dB below the fundamental.
Finally, the functionality of the I/Q demodulator is validated
by measuring the following metrics: offsets, noise, linearity,
and frequency response.
DC offsets appear due to mismatches in the differential
circuits. The DC offsets in the signal generator and LNA
are up-converted by the mixer and removed by the low-pass
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Fig. 18. Signal generator tests
filter. The TIA only process input currents, and therefore
its input referred offset voltage (and also its input referred
1/f noise) is highly attenuated. Accordingly, the dominant
contributor to the offset is the continuous-time filter. The DC
offset is superimposed to the result of the I/Q demodulator, and
therefore, it should be carefully measured and compensated.
Typically, a calibration loop is used in order to mitigate the
offset. In this work, DC output offsets are first measured and
subsequently subtracted from I/Q measurements by software.
The offset measurement requires that the signal generator is
disabled (VIN = 0 V), while the I/Q clock is active. The
measured differential offset voltages in the tested samples are
below 50 mV.
Fig. 19 shows the noise measured at one of the differential
outputs which has a value of around 1.63 mVrms. The
noise is dominated by 1/f noise coming from the filter.
When taken differentially, it will slightly exceed the total
output simulated noise; however, it is important to take into
consideration that this is a single ended measurement, and
therefore this measurement includes common-mode and power
supply noise sources. As mentioned in previous sections, low
frequency noise can be mitigated in DC measurements by
taking multiple measurements and performing averaging. The
averaging is performed in software where the number of taps
is configurable (default number is 32).
The linearity of the bio-impedance sensor was evaluated by
measuring resistors from 50 Ω to 2.5 kΩ (range of interest in
this application). Such a large dynamic range requires variable
gains which are digitally controlled by the configuration bits
G0, G1, and G2. Fig. 20 shows the linearity curves for
different gain settings. The gain settings are defined as the
digital word G0G1G2. When all the gain bits are enabled
(111), the response is linear up to around 400 Ω. Then
the system starts to exhibit compression and therefore it is
necessary to switch to 101. This gain remains linear up to
around 1.2 kΩ where it starts to compress. At this level it
is necessary to switch the gain to 001, which guarantees
very good linear response for levels up to around 3.6 kΩ. In
addition, higher impedances can be measured if G2 is disabled.
Although not designed for measuring high impedance tissues
Fig. 19. Output noise waveform and spectrum
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Fig. 20. Measured resistance values for different gains
(skin or fat), disabling G2 can extend the application of this
ASIC to measure impedances up to around 11 kΩ.
The frequency response was characterized by assuming a
“Debye-type” electrical model for the tissues. In this model,
tissues can be represented by the parallel combination of a
resistor and a capacitor. Different combinations of resistors and
capacitors in the relevant range were measured. The values of
resistors and capacitors were selected based on the results from
Section II-A. Fig. 21(a) and Fig. 21(b) show the impedance
magnitude and phase for a 0.1 nF capacitor in parallel to a
1 kΩ resistor. At around 2 kHz, the impedance magnitude is
close to 600 Ω whereas at 125 kHz the impedance drops to
around 13 Ω. Measurements at higher frequencies result in
very small impedance values which are too close to the noise
level and therefore they are disregarded. It is interesting to
notice than even for a value as small as 13 Ω, the phase error
is still only a couple of degrees.
The previous measurements with discrete components pro-
vide valuable information of the system’s performance. How-
ever, the electrical characteristics of biological tissues are
defined by electrochemical properties and therefore an electro-
chemical characterization of the bio-impedance ASIC is more
suitable.
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Fig. 21. Impedance magnitude (a) and phase (b) of 0.1 nF capacitor in paralell
to 1 kΩ resistor
B. Electrochemical Tests
Fig. 22(a) and Fig. 22(b) show measurements and simula-
tions of impedance magnitude and phase for sterile physio-
logical solution (0.90 % NaCl, σ ≈ 1.584 S/m, εr ≈ 78).
The simulation was performed by extracting Z21 parameters
by using the EM simulation setup described in Section II.
Ten measurements were taken for each frequency. The sim-
ulated impedance has a magnitude of approximately 47 Ω at
low frequencies and starts to drop at around 30 MHz. The
measured impedance has a magnitude of approximately 52 Ω
at low frequencies and starts to drop at around 250 kHz.
It can be seen that the EM simulation follows very well
the measurement at low frequencies with only around 5 Ω
difference. This is a very encouraging result considering the
rough approximations done during the EM simulation. On
the other hand, the measurements start diverging from the
simulation above 250 kHz. The differences are attributed
to the first pole in the LNA which is located just above
2 MHz and that is low-pass filtering the signal. The filtering
effect is reflected both in magnitude reduction and phase shift
which are crucial parameters in the impedance measurements.
Calibration mechanisms implemented in the analog domain
have been proposed in order to tackle this problem [28]. In
this work, since the offending pole is inside the amplification
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Fig. 22. Measured Impedance magnitude (a) and phase (b) of saline solution
chain and totally isolated from the electrodes, it is possible
to apply a correction mechanism based on equalization. The
proposed calibration process consists on measuring a known
impedance, i.e. 100 Ω, and finding the calibration coefficients
that are needed to correct each frequency component (both
magnitude and phase). The calibration needs to be done only
once, and when these coefficients are known, they are saved
and can be reused to perform the correction in software (either
in the microcontroller or in the Android phone). The green
lines show the measurements that are calibrated using this
method.
Finally, it can be seen that the standard error of the mea-
surements is below 1 Ωrms for frequencies above 4 kHz, and
increases to 2.6 Ωrms at 2 kHz. This increase is attributed
to larger amounts of 1/f noise entering in the system. As
discussed before, increasing the number of taps in the average
filter reduces this noise to the quantization level at the expense
of larger observation time.
C. Ex Vivo Tests
The final validation of the ASIC consists of performing
ex vivo impedance measurements on sheep’s liver and kidney
at 8 kHz and 1 MHz (1 point in the lower half of the β
dispertion and 1 point in the upper end of the β dispersion
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range of frequencies [1]). Fig. 23 shows the complete mea-
surement setup: the Android mobile phone where the user
application is installed, the external reader prototype running
on batteries, the implantable device prototype, and the gold
electrodes. The measurement procedure was as follows. The
measurements started 25 minutes after circulation stopped
(Time zero in Fig. 24(a) and Fig. 24(b)), and lasted for
several hours. A gold electrode probe was introduced in an
incision done in each organ. In addition, another probe was
fixed on the surface of the organs. The organs were deposited
in plastic bags which were introduced in bowls filled with
water. The water’s temperature was constantly monitored and
kept at around 37◦C. Fig. 24(a) and Fig. 24(b) show the
measured impedance’s magnitude and phase respectively for
the probes introduced in the incisions (Int.) and the ones
attached externally (Ext.). It is observed that the magnitude
at low frequencies increases a few hundreds of Ω, remains
relatively constant for some time, and then decreases in some
cases below its initial value. On the other hand, the magnitude
at 1 MHz remains relatively constant with values of a few
hundreds of Ω. The measured phase at 8 kHz follows the
pattern of the measured impedance at the same frequency:
first it increases, peaks for some time, and then it decreases.
This pattern can be partially explained by noticing that for
a very simple parallel RC model, an increase in R shifts the
cut-off frequency to lower frequencies while increasing phase
shift at higher frequencies. The behavior of the measured bio-
impedances is in agreement with previous observations of
ischemia in organs, where two factors inherent in R would
be attributed to closing of gap junctions within a few hours
after stop of circulation, followed later by rupture/lysis of
cell membranes. A full decay of cell membranes would take
another 10 hours or so, depending on temperature, and result
in a lower impedance at the lower frequency than observed
from the very beginning [29].
The ex vivo measurements confirm that the proposed ASIC
accomplishes its target specifications, and therefore it can
be successfully used to determine the bio-impedance of a
variety of tissues in medical applications. The magnitude of
the measured bio-impedances also confirm that the initial
specifications, set for the minimum and maximum impedances,
are at the correct levels. Furthermore, the measurements show
that very accurate and stable measurements with a resolution
of 1 Ω are possible even in ex vivo conditions.
V. CONCLUSION
This paper presented a 2-kHz to 2-MHz bio-impedance
sensor ASIC that targets implantable biomedical applications.
The ASIC is designed in 150 nm CMOS technology and
consumes 165 µA at 1.8 V when powered by an external
reader. The proposed ASIC has been validated by performing
electrical, electrochemical, and ex vivo measurements. All
measurement results show that the proposed solution achieves
around 1 Ω resolution when sensing a 100 Ω impedance (1%
error). In real medical applications, the tissues present larger
impedance values; therefore, making possible better sensitivity
Fig. 23. Ex vivo test on sheep’s liver and kidney
levels. The measurement results show that this ASIC is able
to successfully meet the bio-impedance sensing requirements
while at the same time allowing a miniature size, battery-less
implantable solution.
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